Mar 23, 2016 at 10:34 | Source: CNBC-TV18
Ajay Srivastava, CEO, Dimensions Consulting, cautions against going short on other sectors though fourth quarter numbers in most cases are expected to worse than the third quarter numbers. That is because there is too much liquidity in the system right now forcing share prices higher in the short term irrespective of fundamentals
Feb 16, 2016 at 09:15 | Source: Moneycontrol.com
Vivimed Labs has reported a consolidated total income from operations of Rs 331.88 crore and a net profit of Rs 23.02 crore for the quarter ended Dec '15
Jan 18, 2016 at 11:18 | Source: CNBC-TV18
SP Tulsian of sptulsian.com is of the view that Vivimed Labs may test Rs 500 in next six months.
Jan 15, 2016 at 12:58 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Vivimed Labs, Suzlon Energy, Aban Offshore, Marksans Pharma, Prakash Industries, Infosys, IndiGo, Cyient, Wockhardt & Strides Shasun.
Jan 12, 2016 at 11:04 | Source: Moneycontrol.com
In the board meeting held on January 11, 2016, it has approved the sub division of its equity shares from the existing face value of Rs 10 to Rs 2 per equity share.
Dec 24, 2015 at 12:55 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Pipavav Defence, Bharat Forge, Biocon, Tree House, Zee Media, Vivimed, Aurobindo Pharma and Autoline Industries.
Dec 24, 2015 at 12:40 | Source: PTI
"The Competition Commission of India vide its letter dated December 21, 2015, has granted its approval, under Section 31(1) of the Competition Act, 2002, with respect to the proposed acquisition of certain products in Speciality Chemicals division of the company by Clariant India Ltd," Vivimed Labs said in a BSE filing.
Dec 17, 2015 at 21:16 | Source: Moneycontrol.com
Vivimed Labs has informed that Mr. Srinivas Chidambaram, Non-Independent and Non- executive Director (Nominee Director) has submitted his resignation from the Board of Directors of the Company with immediate effect vide his letter dated December 16, 2015 (received on December 17, 2015).
Nov 20, 2015 at 16:51 | Source: Moneycontrol.com
Karvy is bullish on Vivimed Labs and has recommended buy rating on the stock with a target of Rs 443 in its November 20, 2015 research report.
Nov 16, 2015 at 14:05 | Source: Moneycontrol.com
Vivimed Labs has reported a consolidated total income from operations of Rs 341.55 crore and a net profit of Rs 23.88 crore for the quarter ended Sep '15